Your browser doesn't support javascript.
loading
The longitudinal analysis for the association between smoking and the risk of depressive symptoms.
Park, Sung Keun; Oh, Chang-Mo; Kim, Eugene; Ryoo, Jae-Hong; Jung, Ju Young.
Affiliation
  • Park SK; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Oh CM; Departments of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.
  • Kim E; Department of Orthopaedic Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ryoo JH; Departments of Occupational and Environmental Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.
  • Jung JY; Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, Korea. jjy0501@naver.com.
BMC Psychiatry ; 24(1): 364, 2024 May 15.
Article de En | MEDLINE | ID: mdl-38750466
ABSTRACT

BACKGROUND:

Despite high smoking rate in people with depressive symptoms, there is ongoing debate about relationship between smoking and depressive symptoms.

METHODS:

Study participants were 57,441 Korean men. We collected their baseline data between 2011 and 2012, and conducted follow-up from 2013 to 2019. They were categorized by smoking status (never < 100 cigarettes smoking in life time, former currently quitting smoking, and current smoker currently smoking), smoking amount (pack/day and pack-year) and urine cotinine excretion. The development of depressive symptoms was determined in CES-D score ≥ 16. Cox proportional hazards model was used to analyze the multivariable-adjusted hazard ratio (HR) and 95% confidence intervals (CI) for depressive symptoms in relation to smoking status, smoking amount, and urine cotinine excretion.

RESULTS:

During 6.7 years of median follow-up, the risk of depressive symptoms increased in order of never (reference), former (HR = 1.08, 95% CI 1.01-1.15) and current smoker (HR = 1.24, 95% CI 1.16-1.32). Among current smoker, the risk of depressive symptoms increased proportionally to daily smoking amount (< 1 pack; HR = 1.21, 95% CI 1.13-1.29, and ≥ 1 pack; HR = 1.34, 95% CI 1.23 - 1.45). This pattern of relationship was consistently observed for pack-year in former smoker and current smoker. Additionally, urine cotinine excretion was proportionally associated with the risk of depressive symptoms.

CONCLUSION:

Exposure to smoking was associated with the increased risk of depressive symptoms. Dose dependent relationship was observed between smoking amount and the risk of depressive symptoms.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fumer / Cotinine / Dépression Limites: Adult / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: BMC Psychiatry Sujet du journal: PSIQUIATRIA Année: 2024 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fumer / Cotinine / Dépression Limites: Adult / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: BMC Psychiatry Sujet du journal: PSIQUIATRIA Année: 2024 Type de document: Article Pays de publication: Royaume-Uni